The word describes how it is made
An approved medicine may be unable to meet a person’s need, such as avoiding a particular dye; compounding can help in that situation.
The Food and Drug Administration (FDA) is the US agency that carries out medicine reviews. A compounded product has no FDA approval. FDA does not review its quality, benefit, or safety before it reaches patients. That legal position was recorded on September 26, 2026.
There are different kinds of preparation
An ordinary compounding pharmacy can fill a prescription by preparing medicine for the named patient, subject to the relevant conditions.
Another kind of medicine-making facility registers with FDA and prepares sterile medicines in batches, often to supply hospitals or clinics. The name for this is an outsourcing facility. It can prepare batches without a prescription bearing your name. It must meet drug-factory quality rules, and FDA inspects the facility. Sterile means free of living germs.
The September 26, 2026 record makes clear that registration with FDA is not product approval.
The ingredient still has to qualify
For ordinary pharmacy compounding, the law sets conditions for the starting ingredient. Where an official drug-ingredient standard exists, the ingredient must meet it. Without an official standard, the ingredient must be found in an approved medicine or included on FDA’s permitted-ingredient list.
The September 26, 2026 record showed BPC-157 met none of those legal conditions. This describes the rules for pharmacy use, rather than a laboratory result.
Ask the service to name the rule that allows its pharmacy to use BPC-157 and explain how the ingredient meets that rule. Ask for the answer in writing.
Find out who made the product
FDA notes that care websites or apps may leave people unsure which pharmacy or facility made their medicine.
Ask for that name. Then check the pharmacy through the state board of pharmacy, the body that licences pharmacies.